June 27 (Reuters) - Mersana Therapeutics Inc ::Mersana Therapeutics announces pricing of initial public offering.Says initial public offering of 5.00 million common shares priced at $15.00 per share.
June 23 (Reuters) - Amgen Inc ::Amgen receives positive CHMP opinion to expand use of mimpara (cinacalcet) for the treatment of secondary hyperparathyroidism in certain children with end-stage renal disease on dialysis.Amgen Inc - CHMP positive opinion will now be reviewed by European Commission.
June 22 (Reuters) - Celsion Corp ::Celsion Corporation announces cancellation of registered direct offering.Company noted it did not possess ability to register a sufficient number of shares pursuant to form S-3 until July 1, 2017.Company has entered into an agreement with each of investors to...
June 20 (Reuters) - Suda Ltd ::Suda signs term sheet to acquire Novel Oro- Mucosal anti-cancer agent.Signed a binding memorandum of understanding (mou) with UK-based Aluztra Bio Ltd.Under terms of MOU, Suda has up to six months to complete its due diligence on Anagrelide before entering a definitive...
No related earnings announcements are currently scheduled within the next 7 days.